Ajinomoto carries a market cap of approximately ¥3.8 trillion ($25 billion USD) as of early 2026, trading on the Tokyo Stock Exchange under ticker 2802. The food and amino acid company has seen its valuation more than double over five years as investors re-rated its health science and bioscience businesses alongside a recovery in its core seasoning and frozen food segments.
Market Cap Of Ajinomoto
TSE market cap in USD equivalent from the 1949 listing through 2026. JPY/USD at approximate annual average rates. The sharp post-2019 acceleration reflects Ajinomoto's strategic pivot to higher-margin amino acid and healthcare businesses.
Year-On-Year Ajinomoto Market Cap
| Year | Market Cap (USD equiv.) | YoY Change |
|---|---|---|
| 2016 | $9.8B | — |
| 2017 | $10.2B | +4.1% |
| 2018 | $9.4B | −7.8% |
| 2019 | $10.8B | +14.9% |
| 2020 | $11.6B | +7.4% |
| 2021 | $14.4B | +24.1% |
| 2022 | $16.8B | +16.7% |
| 2023 | $20.4B | +21.4% |
| 2024 | $24.0B | +17.6% |
| 2025 | $25.0B | +4.2% |
Note: USD equivalents converted from JPY at approximate annual average exchange rates. Ajinomoto's sustained valuation gains reflect investor confidence in its transformation from a commodity seasoning company into a higher-margin specialty food and life sciences business, particularly through its amino acid contract manufacturing operations.